Astellas Pharma Inc.
ALPMY | OTC
$15.31
+$0.10 (+0.66%)
Sep 22, 2026, 2:21 PM ET · Market open
Market Data
Market Cap $27.27B
Enterprise Value $4.6T
Beta 0.09
Average Volume N/A
Shares Outstanding (Diluted) 1.8B
Shares Change YoY -0.02%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M 1.1%
Price Change 3M 15.6%
Price Change 6M -4.9%
Price Change YTD 14.2%
Price Change 1Y 34.0%
Price Change 3Y 5.7%
Price Change 5Y -11.3%
1M CAGR (ann.) 2.8%
1Y CAGR (ann.) 38.4%
5Y CAGR (ann.) 0.6%
All-Time CAGR 6.8%
Valuation
PE Ratio 50.81
Forward PE 12.16
PEG Ratio 0.03
Forward PEG 12.09
PS Ratio 2.09
Forward PS 1.90
PB Ratio 2.65
P/FCF Ratio 20.27
P/Adj. FCF Ratio 20.27
P/OCF Ratio 6.80
EV/Sales 2.37
EV/EBIT 16.97
EV/EBITDA 9.84
EV/FCF 22.90
Earnings Yield 1.9%
FCF Yield 4.7%
Adj. FCF Yield 4.7%
Financial Health
Net Debt ¥674.09B
Total Debt ¥889.49B
Cash & Short-Term Investments ¥215.4B
Total Assets ¥3.34T
Current Ratio 1.20
Quick Ratio 0.93
Debt / Equity Ratio 0.30
Debt / EBITDA 1.90
Debt / FCF 4.43
OCF / Debt 0.27
Interest Coverage 43.91
Altman Z-Score 2.52
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 74.7%
Operating Profit Margin 5.4%
EBITDA Margin 29.8%
Net Profit Margin 16.0%
FCF Margin 10.3%
Adj. FCF Margin 10.3%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 9.9%
Return on Equity 20.4%
Return on Invested Capital 14.0%
Return on Capital Employed 20.2%
Return on Tangible Assets 16.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 12.9%
Revenue CAGR 5Y 8.8%
Revenue CAGR 10Y 4.2%
EPS CAGR 3Y -11.2%
EPS CAGR 5Y -14.9%
EPS CAGR 10Y -3.8%
FCF CAGR 3Y 1.5%
FCF CAGR 5Y 0.6%
FCF CAGR 10Y 4.6%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 48.1%
Revenue Growth Next 3Y -0.6%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) $0
EPS Growth Est (next Q) 30.1%
Revenue Est (next Q) $23.47M
Revenue Growth Est (next Q) 4.1%
Fair Value Estimates
Graham Number $7.26
Graham Upside -52.3%
Lynch Fair Value $1.50
Lynch Upside -90.1%
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow ¥236.75B
Free Cash Flow ¥200.94B
Adj. Free Cash Flow ¥200.94B
FCF Per Share $301.63
OCF Per Share $333.73
OCF/S Ratio 26.3%
Income Statement
Revenue ¥1.94T
Gross Profit ¥1.59T
Operating Income ¥105.14B
EBITDA ¥467.74B
Net Income ¥81.57B
EPS (Diluted) $44.70
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Dividends
Annual Dividend $0.46
Dividend Yield 3.02%
Payout Ratio 1.0%
FCF Payout Ratio 65.9%
Adj. FCF Payout Ratio 65.9%
Dividend Growth (YoY) -9.1%
Pay Frequency Semi-Annual
Ex-Dividend Date Sep 28, 2026
Add to Watchlist
Select watchlists to add or remove ALPMY